EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study

Sheng-Nan Gao iD, Jin-Song Jia, Xiao-Jun Huang iD, Yuan-Yuan Zhang, Ting-Ting Han iD, Hai-Xia Fu, Yun He, Yao Chen, Jing-Zhi Wang, Xiao-Dong Mo, Yu-Qian Sun, Wei Han und 4 weitere

Stem Cells Translational Medicine · 2026

DOI: 10.1093/stcltm/szag076 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Sheng-Nan Gao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Ke…. Hauptthemen laut MEDLINE: Anemia, Aplastic, Hematopoietic Stem Cell Transplantation, Immunosuppressive Agents, Immunosuppression Therapy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High Innovation Plan, National Key Research and Development Program of China, Major Program of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe aplastic anemia (SAA) is a life-threatening hematological disorder, and the optimal treatment for patients aged ≥40 years remains controversial. This retrospective study aims to conduct a comparative analysis of the efficacy of immunosuppressive therapy (IST) versus haploidentical hematopoietic stem cell transplantation (haplo-HSCT) specifically in elderly patients. To minimize selection bias, propensity score matching (PSM) was performed to pair samples based on age and Eastern Cooperative Oncology Group score, thereby addressing treatment responses and survival outcomes while ensuring balanced baseline characteristics between the 2 groups. The study reveals that while overall survival (OS) rates were similar (69.6% ± 13.3% vs. 68.6% ± 12.1%, P = 0.80), haplo-HSCT significantly outperformed IST in terms of failure-free survival (FFS) rates (68.7% ± 12.1% vs. 46.5% ± 20.2%, P = 0.025). Multivariate Cox regression analysis confirmed that treatment modality and disease severity were independent predictors of FFS. These findings support haplo-HSCT as a viable first-line treatment option for appropriately selected elderly SAA patients, providing evidence for treatment options in patients with SAA aged 40 and above.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticHematopoietic Stem Cell TransplantationImmunosuppressive AgentsImmunosuppression TherapyTransplantation, HaploidenticalHumansFemaleRetrospective StudiesMaleAgedMiddle AgedAdultTreatment OutcomePropensity ScoreDisease-Free Survival

Stichwörter der Autor:innen

elderly patientshaploidentical hematopoietic stem cell transplantationimmunosuppressive therapypropensity score matchingsevere aplastic anemia

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Pe…

ORCID-Profile: Sheng-Nan Gao, Xiao-Jun Huang, Ting-Ting Han

Förderung

  • High Innovation Plan
  • National Key Research and Development Program of China
  • Major Program of the National Natural Science Foundation of China

Zitieren

APA

Gao, S. N., Jia, J. S., Huang, X. J., Zhang, Y. Y., Han, T. T., Fu, H. X., He, Y., Chen, Y., Wang, J. Z., Mo, X. D., Sun, Y. Q., Han, W., Wang, Y., Zhang, X. H., Xu, L. P., & Xu, Z. L. (2026). Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag076

Vancouver

Gao SN, Jia JS, Huang XJ, Zhang YY, Han TT, Fu HX, et al. Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szag076

BibTeX
@article{Gao2026,
  author = {Gao, Sheng-Nan and Jia, Jin-Song and Huang, Xiao-Jun and Zhang, Yuan-Yuan and Han, Ting-Ting and Fu, Hai-Xia and He, Yun and Chen, Yao and Wang, Jing-Zhi and Mo, Xiao-Dong and Sun, Yu-Qian and Han, Wei and Wang, Yu and Zhang, Xiao-Hui and Xu, Lan-Ping and Xu, Zheng-Li},
  title = {Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  doi = {10.1093/stcltm/szag076}
}
Kostenlos starten →